Role of tissue inhibitor of metalloproteinase-3 in prostatic inflammation and prostate cancer progression

Thumbnail Image
Adissu, Hibret A.
Journal Title
Journal ISSN
Volume Title
University of Guelph

Modulation of the extracellular microenvironment by matrix metalloproteases (MMPs) is important in a variety of physiological and pathological processes including inflammation and cancer. Tissue inhibitor of metalloproteinase 3 (TIMP3) is a broad spectrum inhibitor of MMPs and a negative regulator of inflammation, a process implicated in prostate cancer development, progression, and the emergence of hormone-independent disease. In this thesis we explored the role of TIMP3 in prostatic inflammation and prostate cancer progression using genetically engineered mice. Heightened prostatic inflammatory response was observed in 'Timp3-/-' mice following castration, indicating that TIMP3 loss may create a proinflammatory prostate environment conducive to malignant progression. This was tested in a prostate cancer model by crossing TIMP3-deficient mice with prostate-specific PTEN-deficient mice. TIMP3-deficiency promoted tumor growth and invasion, with increased MMP-2 activity, inflammation, and expression of proinflammatory factors implicated in cancer progression. In summary, this study demonstrated that TIMP3-deficiency promotes prostatic inflammation and prostate cancer progression; thus showing the potential of restoring/augmenting TIMP3 activity as a novel therapeutic approach for inflammation-associated neoplasia. Further, this model might be useful to study the pathogenesis of hormone-independent prostate cancer.

Prostate cancer, Metalloproteinase-3, Tissue inhibitor, Prostatic inflammation, Matrix metalloproteases